Shintaro Akiyama

27PUBLICATIONS
31CO-AUTHORS
Cancer geneticsAllergyCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Apr 25, 2026
Reply to "Letter to "Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis"".

|Feb 20, 2026
Exploratory Clinical Study to Evaluate the Efficacy and Safety of Sulfasalazine for Immune Checkpoint Inhibitor (ICI)-Induced Colitis.

Mariko Kobayashi, Takeshi Yamada, Shunsuke Ueyama

|Aug 20, 2025
A Clinical Trial to Evaluate the Safety and Efficacy of Centella asiatica for Ulcerative Colitis.

Xiangning Guo, Hirosumi Suzuki, Taku Sawafuji

|Jul 31, 2025
Letter: Efficacy Versus Effectiveness-An Important Nuance Among Real-World Studies: Authors' Reply.

Shintaro Akiyama, Toshimitsu Fujii

|Jul 30, 2025
Editorial: Evolving Trends in Ulcerative Colitis Management-Insights From the Lothian Cohort.

Shintaro Akiyama

|Jul 08, 2025
Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis: a multicenter I‑BRITE cohort study.

Shintaro Akiyama, Yuka Ito, Mamiko Shiroyama

Pageof 5

Frequent Collaborators

5 joint publications

Atsushi Sakuraba

5 joint publications

Toshimitsu Fujii

2 joint publications

Kiichiro Tsuchiya

2 joint publications

Masayuki Saruta